Assessment of candidate biomarkers of drug-induced hepatobiliary injury in preclinical toxicity studies
- 1 April 2010
- journal article
- research article
- Published by Elsevier BV in Toxicology Letters
- Vol. 196 (1), 1-11
- https://doi.org/10.1016/j.toxlet.2010.03.018
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- Performance of Novel Kidney Biomarkers in Preclinical Toxicity StudiesToxicological Sciences, 2010
- Urinary Biomarkers in the Early Detection of Acute Kidney Injury after Cardiac SurgeryClinical Journal of the American Society of Nephrology, 2009
- Urine NGAL Predicts Severity of Acute Kidney Injury After Cardiac SurgeryClinical Journal of the American Society of Nephrology, 2008
- Increased glutathione levels and activity of PON1 (phenyl acetate esterase) in the liver of rats after a single dose of cyclophosphamide: A defense mechanism?Experimental and Toxicologic Pathology, 2008
- Neutrophil gelatinase-associated lipocalin as the real-time indicator of active kidney damageKidney International, 2007
- Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney diseasePediatric Nephrology, 2007
- Identification of neutrophil gelatinase‐associated lipocalin (NGAL) as a discriminatory marker of the hepatocyte‐secreted protein response to IL‐1β: a proteomic analysisBiotechnology & Bioengineering, 2005
- Serum alanine aminotransferase in skeletal muscle diseasesHepatology, 2005
- Developmental and tissue-specific expression of rat T-KininogenBiochemical and Biophysical Research Communications, 1991
- Major acute-phase alpha(1)protein in the rat: Structure, molecular cloning, and regulation of mRNA levelsBiochemical and Biophysical Research Communications, 1985